University of Gothenburg
  2. About the University
  3. Find staff
  4. Kyong-Su Park

Kyong-Su Park

Researcher

Department of Internal Medicine and Clinical Nutrition
Mail
kyong-su.park@gu.se
Visiting address
Medicinaregatan 1F
413 90 Göteborg
Postal address
Box 424
405 30 Göteborg

About Kyong-Su Park

About Kyong-Su Park

Kyong-Su Park is Associate Professor at Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Sweden. His research interests involve the development of a comprehensive understanding of extracellular vesicles (EV) from mammalian and bacteria with over 18 years experiences in molecular biology, microbiology and immunology. Especially, he pursues to develop the technology to manipulate bio-mimetic EV such as synthetic eukaryotic vesicles (SyEV) and synthetic bacterial vesicles (SyBV), and then translate the SyEV/SyBV platform into specific therapeutics for inflammation and cancer.

He received his PhD in 2014 from Pohang University of Science and Technology (POSTECH), South Korea, under the supervision of Prof. Yong Song Gho. Following the completion of his doctoral studies, he worked at Hanmi Pharmaceutical Co., Ltd., South Korea (2014-2016), where he gained clinical experience and focused on clinical development strategies for anti-diabetic and anti-obesity drugs. He then returned to the EV field and worked as a postdoctoral fellow (2016-2021) in collaboration with Prof. Jan Lötvall at the Krefting Research Centre. Since 2022, he has been permanently employed in the same department.

His research has not only focused on the medical application of EV but also on understanding molecular mechanisms underlying disease pathogenesis. In particular, He has investigated the roles of EV in disease development and progression by identifying molecular pathways and functional biomolecules involved in EV-mediated intercellular communication. Furthermore, he has studied how engineered bio-mimetic EV (from mesenchymal stem cells or bacteria) can function as drug candidates by elucidating their molecular mechanisms of action, including their roles in inducing vaccine responses and therapeutic effects. These studies have resulted in multiple peer-reviewed scientific publications describing molecular mechanisms and functional properties of EV.